Search for: "Cephalon Inc." Results 81 - 100 of 169
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Nov 2010, 2:09 am by sally
Court of Appeal (Criminal Division) Kuku, R. v [2010] EWCA Crim 2533 (13 October 2010) Court of Appeal (Civil Division) KCI Licensing Inc & Ors v Smith & Nephew Plc & Ors [2010] EWCA Civ 1260 (18 November 2010) Starglade Properties Ltd v Nash [2010] EWCA Civ 1314 (19 November 2010) Tilson v Alstom Transport [2010] EWCA Civ 1308 (19 November 2010) Ingram v Williams [2010] EWCA Civ 1313 (19 November 2010) High Court (Queen’s Bench Division) JIH v News Group Newspapers… [read post]
1 Apr 2015, 11:51 am by Montgomery McCracken
On March 23, 2015, the United States District Court for the Eastern District of Pennsylvania denied certification of a nationwide class of third party payors (“TPPs”) asserting unjust enrichment claims against Cephalon, Inc. [read post]
1 Jul 2008, 4:31 am
In previous reports, we noted that a handful of biotech/pharma companies spent significant amounts of money lobbying the federal government in the first quarter of 2008, including: • Abbott Laboratories -- $880,000 • Amgen Inc. -- $2.5 million • Cephalon,... [read post]
31 Mar 2010, 2:37 am
"     FTC's Pay for Delay Case Against Cephalon Moves Forward "The Federal Trade Commission's crusade against "Pay for Delay" patent settlements between brand name and generic drug makers got a boost yesterday when a district court judge refused to dismiss a 2008 antitrust suit against Cephalon Inc. [read post]
6 Aug 2011, 12:18 am by Apeng
 (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon Inc, Cephalon France SAS and Cephalon (UK) Ltd v Orchid Europe Ltd and Generics (UK) Ltd (t/a Mylan) / ???? [read post]
3 Aug 2011, 3:31 am by Marie Louise
Patent and Trademark Office (Orange Book Blog) (IP Watch) (KEI) (Patent Docs) (Patent Docs) (IP Spotlight) (Patently-O) (Inventive Step) (Patentology) (Patent Law Practice Center) (IPBiz) (Out-Law) (PharmaPatents) (Maier & Maier) (Patent Docs) (Patent Baristas) Memantine – EU: CJEU ruling rejects pre-65/65 authorisations: Case C-195/09 Synthon v Merz Pharma (The SPC Blog) (EPLAW) Modafinil – UK: EWHC: Constructing a case for infringing particle-size patents: Cephalon… [read post]
7 Jun 2010, 5:00 am by Michael Kaplen
    Clinical research sites across the world are working with biopharmaceutical company Cephalon, Inc., as part of the study to test the effectiveness and safety of an investigational treatment for people with excessive sleepiness caused by a concussion or head injury. [read post]
15 Jan 2009, 6:39 pm
While Zyprexa has been subject of lawsuits, other drug makers such as Cephalon Inc. [read post]
10 Feb 2010, 4:47 pm
- UK: EWCA dismisses Human Genome Sciences appeal against decision finding invalidity; invention not ‘susceptible of industrial application’: Eli Lilly v Human Genome Sciences Inc (EPLAW) (IPKat) Nuvigil (Armodafinil) – US: Patent infringement complaints filed in Colorado and Delaware following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Cephalon's Nuvigil: Cephalon, Inc. et al.… [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
27 Jun 2011, 2:18 am by sally
Court of Appeal (Criminal Division) Manchester Police, R (On the Application Of) v Hookway & Anor [2011] EWHC 1578 (Admin) (19 May 2011) Attorney General v Fraill & Anor [2011] EWCA Crim 1570 (16 June 2011) Court of Appeal (Civil Division) Zinda v Bank of Scotland Plc [2011] EWCA Civ 706 (23 June 2011) High Court (Chancery Division) Chemistree Homecare Ltd & Ors v Roche Products Ltd [2011] EWHC 1579 (Ch) (16 June 2011) Cowderoy v Cranfield [2011] EWHC 1616 (Ch) (24 June 2011) High… [read post]
28 May 2015, 9:30 pm by RegBlog
Cephalon, Inc. settled with the Federal Trade Commission (FTC) for allegedly reducing competition by preventing the sale of generic versions of the sleep-disorder drug, Provigil. [read post]
22 Oct 2009, 4:23 am
Cephalon, Inc., 2009 WL 3245485 (D.N.J. [read post]